Jill de Mol

6PUBLICATIONS
32CO-AUTHORS
Molecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 23, 2026
Therapeutic Immune Reprogramming by Rapamycin Attenuates Plaque Inflammation and Lymphoid Immune Responses in Aged Atherosclerotic Mice.

|Jul 11, 2026
Age-associated B-cells predict coronary events in humans and aggravate murine atherosclerosis.

|Oct 07, 2025
Progenitor exhausted PD-1+ T cells are cellular targets of immune checkpoint inhibition in atherosclerosis.

Megan Mulholland, Anthi Chalou, Samuel H A Andersson

|Apr 26, 2024
Single-cell T cell receptor sequencing of paired human atherosclerotic plaques and blood reveals autoimmune-like features of expanded effector T cells.

Marie A C Depuydt, Frank H Schaftenaar, Koen H M Prange

|Apr 25, 2024
Immunoproteasomal Inhibition With ONX-0914 Attenuates Atherosclerosis and Reduces White Adipose Tissue Mass and Metabolic Syndrome in Mice.

Frank H Schaftenaar, Andrea D van Dam, Gerjan de Bruin

Pageof 1

Frequent Collaborators

5 joint publications

Marie Depuydt

5 joint publications

Amanda C Foks

4 joint publications

Bram Slütter

3 joint publications

Ilze Bot